Anacor Pharma reports positive preliminary results from two safety studies of ... pharmabiz.com AN2728 has previously demonstrated safety and efficacy in multiple state of matter I and II trials for mild-to-moderate psoriasis and most recently in type A phase II A examination in atopic dermatitis. “These data confirm the status of AN2728 and the potential for it to ... Avoid This Biotech Stock DailyFinance all ii news articles » Link To Article
No comments:
Post a Comment